Correlation Between Mineralys Therapeutics, and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Tempest Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Tempest Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Tempest Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Mineralys and Tempest is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Tempest Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.27 times more return on investment than Tempest Therapeutics. However, Mineralys Therapeutics, is 1.27 times more volatile than Tempest Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 924.00 in Mineralys Therapeutics, Common on November 18, 2024 and sell it today you would earn a total of 100.00 from holding Mineralys Therapeutics, Common or generate 10.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Mineralys Therapeutics, Common vs. Tempest Therapeutics
Performance |
Timeline |
Mineralys Therapeutics, |
Tempest Therapeutics |
Mineralys Therapeutics, and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mineralys Therapeutics, and Tempest Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.Mineralys Therapeutics, vs. Enel Chile SA | Mineralys Therapeutics, vs. BJs Restaurants | Mineralys Therapeutics, vs. Rave Restaurant Group | Mineralys Therapeutics, vs. Kinetik Holdings |
Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |